As previously highlighted, BAFF plays a role in B-cell repopulation following rituximab-induced depletion in warm AIHA, making it a target to prevent relapse via BAFF modulation (88). The gene discussed is TNFSF13B; the disease is autoimmune hemolytic anemia.